Literature DB >> 26491397

Corrigendum to "Outcome of Rhabdomyosarcoma in First Year of Life: Children's Cancer Hospital 57357 Egypt".

Enas El Nadi1, Emad A H Moussa2, Wael Zekri2, Hala Taha3, Alaa Yones4, Mohamed Saad Zaghloul5, Madeeha El Wakeel6, Rania M Labib7.   

Abstract

[This corrects the article DOI: 10.1155/2013/439213.].

Entities:  

Year:  2015        PMID： 26491397      PMCID： PMC4605368          DOI： 10.1155/2015/721253

Source DB:  PubMed          Journal:  Sarcoma        ISSN： 1357-714X


In the paper titled “Outcome of Rhabdomyosarcoma in First Year of Life: Children's Cancer Hospital 57357 Egypt” [1], Enas El Nadi has an additional affiliation and it is added here.
  1 in total

1.  Outcome of Rhabdomyosarcoma in First Year of Life: Children's Cancer Hospital 57357 Egypt.

Authors:  Enas El Nadi; Emad A H Moussa; Wael Zekri; Hala Taha; Alaa Yones; Mohamed Saad Zaghloul; Madeeha El Wakeel; Rania M Labib
Journal:  Sarcoma       Date:  2013-07-25
  1 in total
  1 in total

1.  Curcumin loaded zinc oxide nanoparticles for activity-enhanced antibacterial and anticancer applications.

Authors:  W P T D Perera; Ranga K Dissanayake; U I Ranatunga; N M Hettiarachchi; K D C Perera; Janitha M Unagolla; R T De Silva; L R Pahalagedara
Journal:  RSC Adv       Date:  2020-08-19       Impact factor: 4.036
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.